Articles by Robert Langreth | Fortune

Skip to Content

SIGN IN

Health
Gilead to charge thousands for coronavirus treatment drug that critics say should cost $1
By
Robert Langreth
and
Bloomberg
June 29, 2020
Health
How accurate are the coronavirus tests used by the White House? A new report is raising questions
By
Michelle Fay Cortez,
Robert Langreth,
and others
May 13, 2020
Finance
Gilead shares fall on report of coronavirus drug trial
By
Drew Armstrong,
Robert Langreth,
and others
April 23, 2020
Health
Young people are getting extremely sick from coronavirus, according to new evidence
By
Michelle Cortez,
Angelica LaVito,
and others
March 19, 2020
International
‘Tip of the iceberg:’ Why Covid-19 deaths will keep rising even as the coronavirus outbreak wanes
By
Robert Langreth,
Michelle Fay Cortez,
and others
February 13, 2020
Retail
Walgreens Joins Walmart and Kroger in Saying No Guns in Our Stores
By
Polly Mosendz,
Robert Langreth,
and others
September 5, 2019
Briefing
Rite-Aid's C-Suite Execs Step Down as Pharmacy Chain Tries to Heal Itself
By
Robert Langreth
and
Bloomberg
March 12, 2019
Briefing
CVS Stock Plummets as 2019 Looks Like It Will Be a ‘Major Disappointment’ for Investors
By
Bloomberg
and
Robert Langreth
February 20, 2019

1 - 8 of 8 results

1 - 8 of 8 results

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Info | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.